Catalyx is proud to share that we have been shortlisted for two significant honours at this year’s Irish Pharma Industry Awards. Our organization has been named a finalist for Pharma Supplier of the Year, and our colleague Vivian Linehan has been recognized individually through her shortlisting for the Women in Pharma Award.
This dual recognition highlights the dedication, expertise and commitment to excellence that define our teams and the people who lead them.
The Irish Pharma Industry Awards celebrate excellence, innovation and leadership across one of Europe’s most influential life sciences hubs. The event brings together global and domestic organizations whose work advances manufacturing, supply chain, science, talent development and operational excellence. Being named a finalist is seen as a mark of distinction within a sector that plays a major role in global medicine supply and healthcare progress.
Vivian Linehan, Director of Functional Service Provision at Catalyx, has earned her place among the finalists for the Women in Pharma Award through a career marked by vision, mentorship and continuous innovation. Her leadership has shaped a highly successful Functional Service Provision model that supports global clients with trusted, agile and high performing teams across Quality, Manufacturing, Supply Chain and Packaging. Vivian’s influence reaches far beyond operations, fostering a culture where people grow, thrive and advance. Her recognition reflects her outstanding impact on both Catalyx and the wider pharmaceutical community.
Catalyx is also delighted to be shortlisted for Pharma Supplier of the Year. This recognition is closely tied to the success of our partnership with a leading pharmaceutical client, where our adaptable and scalable Functional Service Provision model has redefined workforce delivery. Through this model, our teams have enabled the client to expand operations with confidence while consistently meeting key performance indicators, strengthening processes, and significantly lowering attrition across supported functions. This collaboration demonstrates the real value of combining specialized expertise with a people centered approach, resulting in measurable improvements and a resilient partnership that continues to grow year after year.
We extend our congratulations to all fellow finalists and look forward to joining the industry on Thursday 20th November in Dublin. These awards celebrate the innovation, progress and collaboration that continue to advance excellence across the pharmaceutical landscape, and we are honored to play a meaningful role in that story. Catalyx looks forward to celebrating this moment with our teams, our clients and our partners as we continue shaping a stronger and more dynamic future for our industry.